With its hepatitis C protease inhibitor progressing in Phase III, Medivir starts to transform itself into a profitable specialty pharmaceutical company.

Carole Ben-Maimon presented Barr's Plan B Rx-to-OTC switch application to FDA's Nonprescription Drugs and Reproductive Health Drugs advisory committees.

Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.